We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
CELECOXIB HOVID (Hovid Australia Pty Ltd)
Product name
CELECOXIB HOVID
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
136 (255 working days)
Active ingredients
celecoxib
Registration type
New generic medicine
Indication
- For the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
- For the treatment of primary dysmenorrhoea in adults.
- For the short-term treatment of acute pain in adults following surgery or musculoskeletal and/or soft tissue injury.